Patent · US Expired

Interleukin-1 receptor antagonist and recombinant production thereof

US6337072B1 · kind B1 · utility

65Cited by
44References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 7, 1999
Grant dateJan 8, 2002
Priority date
Expiry dateJul 7, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel nucleic acids, the novel polypeptide sequences encoded by these nucleic acids and uses thereof. These novel polynucleotide and polypeptide sequences were determined to be a novel Interleukin-1 Receptor Antagonist.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.